S

SR One portfolio

SR One has 3 portfolio companies on record at Recent Funding. It led 2 of the 3 rounds it joined. Its most recent investment on record is Avalyn Pharma's $100M Series B+ round in September 2023, which it led, alongside Wellington Management, Vida Ventures, T. Rowe Price and 6 others. By category, its portfolio leans toward Health and bio (3) and Legal and compliance (1). It has co-invested with Pivotal bioVenture Partners, MRL Ventures Fund and Sofinnova Partners, most often Pivotal bioVenture Partners (2 rounds).

What SR One invests in

• Health and bio · 3 · 100%
• Legal and compliance · 1 · 33%
• Data and analytics · 1 · 33%

SR One recent investments

Company	Round	Date	Alongside
AAvalyn Pharma	Series B+ · $100M · lead	Sep 27, 2023	Wellington Management, Vida Ventures, T. Rowe Price +6
HHotSpot Therapeutics	Series B+ · $100M	Nov 29, 2021	Tekla Capital Management, Sofinnova Partners, Revelation Partners +6
HHotSpot Therapeutics	Series B+ · $65M · lead	May 21, 2020	Tekla Capital Management, Solasta Ventures, Sofinnova Partners +3

How SR One invests

Share is of the 3 rounds on Recent Funding that name SR One. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

SR One portfolio companies

• AAvalyn Pharma$100MSeries B+ · Sep 2023
• HHotSpot Therapeutics$100MSeries B+ · Nov 2021
• AAddition Therapeuticsbacker

Company	Round with SR One	Total raised	Latest raise
AAvalyn Pharma Health and bio	Sep 27, 2023 Series B+ · $100M · lead	$135.5M	Sep 27, 2023 Series B+
HHotSpot Therapeutics Legal and compliance	Nov 29, 2021 Series B+ · $100M	$210M	Nov 29, 2021 Series B+
AAddition Therapeutics Health and bio	backer	$100M	Dec 17, 2025 round

Most frequent co-investors

• PPivotal bioVenture Partners2 shared rounds · last Sep 27, 2023
• MMRL Ventures Fund2 shared rounds · last Nov 29, 2021
• SSofinnova Partners2 shared rounds · last Nov 29, 2021
• TTekla Capital Management2 shared rounds · last Nov 29, 2021
• WWellington Management1 shared round · last Sep 27, 2023
• TT. Rowe Price1 shared round · last Sep 27, 2023
• RRock Springs Capital1 shared round · last Sep 27, 2023
• RRiverVest1 shared round · last Sep 27, 2023
• VVida Ventures1 shared round · last Sep 27, 2023
• TTPG Biotech1 shared round · last Sep 27, 2023
• SSuvretta Capital Management1 shared round · last Sep 27, 2023
• SSurveyor Capital1 shared round · last Sep 27, 2023

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• BBlue Cloud Ventures3 companies · 3 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo
• KKorea Credit Guarantee Fund3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists SR One, which is a subset of its real portfolio. API: /api/v1/investors/sr-one (get a free API key). More: the most active VC firms and new venture capital funds.